References
- Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J 2005;24 (Suppl):S104–8
- Wirsing von Konig CH, Halperin S, Riffelmann M, et al. Pertussis of adults and infants. Lancet 2002;2:774–50
- Bonmarin I, Laurent E, Guiso N, et al. RENACOQ: surveillance de la coqueluche à l’hôpital en 2002. BEH 2004;44:211–2
- Campins-Marti M, Cheng HK, Forsyth K, et al. International Consensus Group on Pertussis Immunisation. Recommendations are needed for adolescent and adult pertussis immunisation: rationale and strategies for consideration. Vaccine 2002;20:641–6
- Forsyth KD, Campins-Marti M, Caro J, et al. For The global pertussis initiative. New pertussis vaccination strategies beyond infancy: recommendations by the global pertussis initiative. CID 2004;39:1802–9
- Van der Wielen M, Van Damme P, Joossens E, et al. A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults. Vaccine 2000;18:2075–82
- Turnbull FM, Heath TC, Jalaludin BB, et al. A randomized trial of two acellular pertussis vaccines (dTpa and pa) and a licensed diphtheria-tetanus vaccine (Td) in adults. Vaccine 2000;19:628–36
- Grimprel E, von Sonnenburg F, Saenger R, et al. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults. Vaccine 2005;23:3657–67
- Hoel T, Wolter JM, Schuerman LM. Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults. Eur J Emerg Med 2006;13:67–71
- Van Damme P, Burgess M. Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults. Vaccine 2004;22:305–8
- Wassilak SGF, Roper MH, Murphy TV, et al. Tetanus toxoid. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th edn. Philadelphia P.A.: Saunders, 2004
- Advisory Committee on Immunization Practices (ACIP). Recommended adult immunization schedule – United States, October 2005–September 2006. MMWR 2005;54:Q1–4
- Gidding H, Backhouse J, Burgess M, et al. Immunity to diphtheria and tetanus in Australia: a national serosurvey. Med J Aus 2005;83:301–4
- McQuillan GM, Kruszon-Moran D, Deforest A, et al. Serologic immunity to diphtheria and tetanus in the United States. Ann Intern Med 2002;136:660–6
- Edmunds W, Pebody R, Aggerback H, et al. The seroepidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. Epidemiol Infect 2000;125:113–25 (erratum Epidemiol Infect 2001;126: 331)
- De Zoysa A, Efstratiou A, European Diphtheria Surveillance Network. Eighth International Meeting of the European Laboratory Working Group on Diphtheria and the Diphtheria Surveillance Network – June 2004: progress is needed to sustain control of diphtheria in European Region. Euro Surveill 2004;9: 47–50
- Granstrom M, Granstrom G. Serological correlates in whooping cough. Vaccine 1993;11:445–8
- Storsaeter J, Hallander HO, Gustafsson L, et al. Low levels of anti pertussis antibodies plus lack of history of pertussis correlate with susceptibility after household exposure to Bordetella pertussis. Vaccine 2003;21:3542–9
- Woo EJ, Burwen DR, Gatumu SN, et al. Extensive limb swelling after immunization: reports to the Vaccine Adverse Event Reporting System. Clin Infect Dis 2003;37:351–8